Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease DOI Creative Commons
Erika N. Cline, Daniel Antwi‐Berko,

Karen Sundell

et al.

The Journal of Prevention of Alzheimer s Disease, Journal Year: 2025, Volume and Issue: unknown, P. 100082 - 100082

Published: Feb. 1, 2025

Language: Английский

Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease DOI Creative Commons
Erika N. Cline, Daniel Antwi‐Berko,

Karen Sundell

et al.

The Journal of Prevention of Alzheimer s Disease, Journal Year: 2025, Volume and Issue: unknown, P. 100082 - 100082

Published: Feb. 1, 2025

Language: Английский

Citations

1